| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $127.3M | -12.3% |
| Cost of Revenue | $65.5M | -4.1% |
| R&D Expense | $70.8M | +1.9% |
| SG&A Expense | $143.1M | +23.9% |
| Operating Income | -$152.2M | -40.6% |
| Interest Expense | $7.5M | +0.0% |
| Pre-tax Income | -$159.2M | -38.4% |
| Income Tax | $317K | +89.8% |
| Net Income | -$159.5M | -38.4% |
| EPS (Basic) | -$3.44 | -35.4% |
| EPS (Diluted) | -$3.44 | -35.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.3M | +4.8% |
| Accounts Receivable | $31.5M | -21.5% |
| Inventory | $43.3M | +37.4% |
| Current Assets | $286.8M | -32.9% |
| Total Assets | $353.4M | -26.3% |
| Current Liabilities | $58.9M | +12.9% |
| Long-term Debt | $226.6M | +0.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$128.6M | -42.0% |
| Capital Expenditures | $14.4M | +126.3% |
| Investing Cash Flow | $132.5M | +160.2% |
| Financing Cash Flow | $2.3M | -62.5% |
| Free Cash Flow | -$143.0M | -47.5% |
| Total Liabilities |
| $307.6M |
| +1.7% |
| Stockholders' Equity | $45.8M | -74.1% |